NewAmsterdam Pharma (NAMS) outlook: obicetrapib could cut cardiovascular risk beyond LDL-C. Key catalysts into 2026–27; ...
Fifty years of weather data is helping western Queensland graziers adapt to hotter conditions by changing breeding schedules ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results